Please Note: This is an On Demand product, delivery may take up to 11 working days after payment has been received.
Table of Contents
Heart Failure with Reduced Ejection Fraction and COVID-19, when the Sick Get Sicker: Unmasking Racial and Ethnic Inequities During a PandemicThe Economic Burden of Heart Failure with Reduced Ejection Fraction: Living Longer but Poorer?
Sequencing Quadruple Therapy for Heart Failure with Reduced Ejection Fraction: Does It Really Matter?
Frailty and Its Implications in Heart Failure with Reduced Ejection Fraction: Impact on Prognosis and Treatment
Obesity in Heart Failure with Reduced Ejection Fraction: Time to Address the Elephant in the Room
The Uncertain Benefit from Implantable Cardioverter-Defibrillators in Nonischemic Cardiomyopathy: How to Guide Clinical Decision-Making?
The War Against Heart Failure Hospitalizations: Remote Monitoring and the Case for Expanding Criteria
Secondary Mitral Regurgitation and Transcatheter Mitral Valve Therapies: Do They Have a Role in Advanced Heart Failure with Reduced Ejection Fraction?
Guide to Temporary Mechanical Support in Cardiogenic Shock: Choosing Wisely
When all Else Fails, Try This: The HeartMate III Left Ventricle Assist Device